The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Pharmacological Reports

• Publication date

  2024-08-20

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s43440-024-00638-wPMID 39162986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unraveling the hepatic stellate cells mediated mechanisms in aging's influence on liver fibrosis

  2024cited by this paper
• Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cited by this paper
• Enhanced liver fibrosis score is stable after withdrawal in patients with heavy alcohol consumption: A pilot study.

  2024cited by this paper
• Bioaccessibility and Bioavailability of Diet Polyphenols and Their Modulation of Gut Microbiota

  2023cited by this paper
• Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway.

  2023cited by this paper
• Impact of Direct-Acting Antiviral Therapy on Liver Fibrosis Regression among People with Chronic HCV Infection: Results from a Real-Life Cohort in Patients Who Achieved Sustained Virological Response

  2023cited by this paper
• Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease.

  2023cited by this paper
• Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS

  2022cited by this paper
• Does CB-1 in hepatic stellate cells contribute to liver fibrosis?

  2022cited by this paper
• NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss

  2022cited by this paper
• Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.

  2022cited by this paper
• Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways.

  2022cited by this paper
• Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

  2022cited by this paper
• DNA methylation profile of liver tissue in end-stage cholestatic liver disease

  2022cited by this paper
• Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.

  2022cited by this paper
• Hepatic stellate cell activation by TGFβ induces hedgehog signaling and endoplasmic reticulum stress simultaneously.

  2022cited by this paper
• Paeoniflorin mitigates PBC-induced liver fibrosis by repressing NLRP3 formation

  2022cited by this paper
• Mannan-Binding Lectin via Interaction With Cell Surface Calreticulin Promotes Senescence of Activated Hepatic Stellate Cells to Limit Liver Fibrosis Progression

  2022cited by this paper
• Hepatic stellate cells in physiology and pathology

  2022cited by this paper
• Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH

  2022cited by this paper
• Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling

  2022cited by this paper
• High-fat diet intake ameliorates the expression of hedgehog signaling pathway in adult rat liver

  2022cited by this paper
• Enhanced Liver Fibrosis Score: Is It Useful for Evaluation of Fibrosis Severity in Chronic Hepatitis C Infection?

  2022cited by this paper
• A double-edged sword: The Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease.

  2021cited by this paper
• Fibrocytes in primary myelofibrosis

  2021cited by this paper
• Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury

  2021cited by this paper
• Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation

  2021cited by this paper
• Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.

  2021cited by this paper
• Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

  2021cited by this paper
• Oxidative Stress—A Key Player in the Course of Alcohol-Related Liver Disease

  2021cited by this paper
• Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway

  2021cited by this paper
• CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells

  2021cited by this paper
• TGF‐β signaling: A recap of SMAD‐independent and SMAD‐dependent pathways

  2021cited by this paper
• Pathophysiological Communication between Hepatocytes and Non-Parenchymal Cells in Liver Injury from NAFLD to Liver Fibrosis.

  2021cited by this paper
• A magnetic resonance imaging modality for non‐invasively distinguishing progression of liver fibrosis by visualizing hepatic platelet‐derived growth factor receptor‐beta expression in mice

  2021cited by this paper
• Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis

  2021cited by this paper
• Vanillic Acid and Non-Alcoholic Fatty Liver Disease: A Focus on AMPK in Adipose and Liver Tissues.

  2021cited by this paper
• The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis

  2021cited by this paper
• Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD

  2021cited by this paper
• Procyanidin B2 alleviates liver injury caused by cold stimulation through Sonic hedgehog signalling and autophagy

  2021cited by this paper
• Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect

  2021cited by this paper
• Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.

  2021cited by this paper
• Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis

  2021cited by this paper
• Liver regeneration and inflammation: from fundamental science to clinical applications

  2021cited by this paper
• The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice

  2021cited by this paper
• Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression

  2021cited by this paper
• Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients.

  2021cited by this paper
• An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS)

  2021cited by this paper
• Efficient Preparation of Black Tea Extract (BTE) with the High Content of Theaflavin Mono- and Digallates and the Protective Effects of BTE on CCl4-Induced Rat Liver and Renal Injury.

  2021cited by this paper
• Novel mouse model for cholestasis‐induced liver fibrosis resolution by cholecystojejunostomy

  2021cited by this paper
• Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes

  2021cited by this paper
• Role of liver sinusoidal endothelial cells in liver diseases

  2021cited by this paper
• CD47‐Mediated Hedgehog/SMO/GLI1 Signaling Promotes Mesenchymal Stem Cell Immunomodulation in Mouse Liver Inflammation

  2021cited by this paper
• Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells

  2021cited by this paper
• TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer

  2021cited by this paper
• Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis.

  2021cited by this paper
• Endothelial dysfunction in pathological processes of chronic liver disease during aging

  2021cited by this paper
• Pterostilbene ameliorates the disrupted Adars expression and improves liver fibrosis in DEN-induced liver injury in Wistar rats: A novel potential effect.

  2021cited by this paper
• Fibrocytes: A Critical Review and Practical Guide

  2021cited by this paper
• The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis

  2021cited by this paper
• Salvianolic acid B inhibits the progression of liver fibrosis in rats via modulation of the Hedgehog signaling pathway

  2021cited by this paper
• Old wine in new bottles: kaempferol is a promising agent for treating the trilogy of liver diseases.

  2021cited by this paper
• Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease

  2021cited by this paper
• Trans-anethole Attenuates Diet-induced Nonalcoholic Steatohepatitis Through Suppressing TGF-β-mediated Fibrosis.

  2021cited by this paper
• Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury

  2021cited by this paper
• Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ

  2021cited by this paper
• Vanillin augments liver regeneration effectively in thioacetamide induced liver fibrosis rat model.

  2021cited by this paper
• Tyrosol retards induction of fibrosis in rats.

  2021cited by this paper
• The Scavenger Function of Liver Sinusoidal Endothelial Cells in Health and Disease

  2021cited by this paper
• Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis

  2021cited by this paper
• Galangin Reverses Hepatic Fibrosis by Inducing HSCs Apoptosis via the PI3K/Akt, Bax/Bcl-2, and Wnt/β-catenin Pathway in LX-2 Cells.

  2020cited by this paper
• Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats

  2020cited by this paper
• Platelet-Derived Growth Factor C in Alcoholics.

  2020cited by this paper
• Connective tissue growth factor in hepatocytes is elevated by carbon tetrachloride via STAT3 activation.

  2020cited by this paper
• Transcriptomics and proteomics analysis of system-level mechanisms in the liver of apigenin-treated fibrotic rats.

  2020cited by this paper
• The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

  2020cited by this paper
• SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway

  2020cited by this paper
• Platelet derived growth factor receptor β (PDGFRβ) is a host receptor for the human malaria parasite adhesin TRAP

  2020cited by this paper
• Pelargonidin ameliorates CCl4-induced liver fibrosis by suppressing the ROS-NLRP3-IL-1β axis via activating the Nrf2 pathway.

  2020cited by this paper
• Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride–induced liver fibrosis in mice

  2020cited by this paper
• Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression?

  2020cited by this paper
• Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.

  2020cited by this paper
• Sirtuin 3‐mediated deacetylation of acyl‐CoA synthetase family member 3 by protocatechuic acid attenuates non‐alcoholic fatty liver disease

  2020cited by this paper
• Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells

  2020cited by this paper
• Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway.

  2020cited by this paper
• Malvidin induces hepatic stellate cell apoptosis via the endoplasmic reticulum stress pathway and mitochondrial pathway

  2020cited by this paper
• Nobiletin alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats.

  2020cited by this paper
• Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-/-mice: role of SIRT1.

  2020cited by this paper
• Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

  2020cited by this paper
• Protection of liver sinusoids by intravenous administration of human Muse cells in a rat extra‐small partial liver transplantation model

  2020cited by this paper
• Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride–induced liver fibrosis in mice

  2020cited by this paper
• Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms.

  2019cited by this paper
• Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways

  2019cited by this paper
• Curcumin mitigates the epithelial‐to‐mesenchymal transition in biliary epithelial cells through upregulating CD109 expression

  2019cited by this paper
• Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling.

  2019cited by this paper
• Carvacrol inhibits cytochrome P450 and protects against binge alcohol-induced liver toxicity.

  2019cited by this paper
• Activated Hepatic Stellate Cells and Portal Fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.

  2019cited by this paper
• Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.

  2019cited by this paper
• Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents

  2019cited by this paper
• (–)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway

  2019cited by this paper

• Advances on Botanicals Targeting Programmed Cell Death in Acetaminophen-Induced Liver Injury.

  2026cites this paper
• The stem bark decoction of Myrianthus arboreus P. Beauv. (Cecropiaceae) shows anti-uterine leiomyoma effects in Wistar rat

  2025cites this paper
• Deubiquitinases in metabolic diseases, fibrosis and cancer of the liver.

  2025cites this paper
• The Emerging Role of Cholesterol Absorption Inhibitors in Reducing Liver Cancer Risk

  2025cites this paper
• Novel regulators of hepatic macrophages in liver fibrosis

  2025cites this paper
• Deubiquitinase USP18 inhibits hepatic stellate cells activation and alleviates liver fibrosis via regulation of TAK1 activity.

  2024cites this paper